ARCHIVES

Galeterone Shows Potential In CRPC AR Variants, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

DCPC Board Defers Two Concepts More Approvals Listed

October 19, 1984

NCI, Dialogue Plan A National Tissue Bank

July 11, 2003

House, Senate Agree On $1.91 Billion NCI Appropriations

September 30, 1994

Tighter Payment Policy

November 5, 2010

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

Year 2000 Objectives In Health On Track

June 25, 1999